MYH9 and central nervous system cancer: Interestingly, one recent research indicates that HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling, which promotes malignant progression and chemoresistance in gliomas 29.